Physician profile
Justin Kang
NPI 1922482785
$3,827.88
in general payments reported to CMS, 2019-2025
7 companies · $216 in 2025
The $216 reported for 2025 was more than what 78% of Dentist providers received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $175 · 2020: $805 · 2021: $28.75 · 2022: $409 · 2023: $1,883 · 2024: $311 · 2025: $216.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $1,750 · Food and Beverage: $660.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $1,750.00 |
| Food and Beverage | $660.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Geistlich Pharma, North America, INC. | $3,639.19 | 2019-2025 | Mucograft, Geistlich Bio-Gide, Biomaterials |
| Straumann USA LLC | $65.77 | 2020 | |
| Align Technology, INC. | $43.28 | 2024 | Invisalign |
| Dentsply Sirona INC | $27.61 | 2020-2021 | |
| Biolase, INC. | $24.56 | 2023 | Waterlase Iplus |
| Orapharma, A Division of Bausch Health US, LLC | $14.47 | 2019 | |
| Philips North America LLC | $13.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justin Kang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.